126 related articles for article (PubMed ID: 23999217)
1. Urological cancer: reduction in the risk of prostate cancer with finasteride.
Marchesi V
Nat Rev Clin Oncol; 2013 Nov; 10(11):608. PubMed ID: 23999217
[No Abstract] [Full Text] [Related]
2. Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score.
Ankerst DP; Till C; Boeck A; Goodman PJ; Tangen CM; Thompson IM
Urology; 2013 Nov; 82(5):1076-81. PubMed ID: 24055241
[TBL] [Abstract][Full Text] [Related]
3. Re: predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and american urological association symptom score.
Babayan RK
J Urol; 2014 May; 191(5):1289. PubMed ID: 24745490
[No Abstract] [Full Text] [Related]
4. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
5. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.
Goetzl MA; Holzbeierlein JM
Nat Clin Pract Urol; 2006 Aug; 3(8):422-9. PubMed ID: 16902518
[TBL] [Abstract][Full Text] [Related]
6. Effect of finasteride on risk of prostate cancer: how little we really know.
Rubin MA; Kantoff PW
J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678
[TBL] [Abstract][Full Text] [Related]
7. [Chemoprevention of cancer of the prostate].
Droz JP
Bull Cancer; 1995 Jul; 82 Suppl 3():178s-180s. PubMed ID: 7492831
[TBL] [Abstract][Full Text] [Related]
8. Finasteride in polycythaemia.
Viegas S; Malone P; Brito-Babapulle F
BJU Int; 2003 Dec; 92 Suppl 3():e60. PubMed ID: 19127639
[No Abstract] [Full Text] [Related]
9. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
Liu Q; Zhu Y; Liu J; Qi J; Kang J
Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
[TBL] [Abstract][Full Text] [Related]
11. Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
Lucia MS; Darke AK; Goodman PJ; La Rosa FG; Parnes HL; Ford LG; Coltman CA; Thompson IM
Cancer Prev Res (Phila); 2008 Aug; 1(3):167-73. PubMed ID: 19138952
[TBL] [Abstract][Full Text] [Related]
12. Authors' reply.
Kumar P; Das A; Lal NR; Jain S; Ghosh A
Indian J Dermatol Venereol Leprol; 2019; 85(3):311-313. PubMed ID: 30971532
[No Abstract] [Full Text] [Related]
13. Chemoprevention for prostate cancer: the Prostate Cancer Prevention Trial.
Fitzpatrick JM
BJU Int; 2003 Sep; 92(4):339-40. PubMed ID: 12930412
[No Abstract] [Full Text] [Related]
14. [Nutritional prevention of urological tumours].
Schmitz-Dräger BJ; Sahin S; Lümmen G; Bismarck E; Fischer C;
Aktuelle Urol; 2014 Jul; 45(4):281-5. PubMed ID: 25166608
[TBL] [Abstract][Full Text] [Related]
15. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
Kristal AR; Till C; Tangen CM; Goodman PJ; Neuhouser ML; Stanczyk FZ; Chu LW; Patel SK; Thompson IM; Reichardt JK; Hoque A; Platz EA; Figg WD; Van Bokhoven A; Lippman SM; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1823-32. PubMed ID: 22879203
[TBL] [Abstract][Full Text] [Related]
16. [Secondary and tertiary prevention of urological tumors].
Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
Urologe A; 2011 Oct; 50(10):1283-7. PubMed ID: 21947262
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of prostate cancer: lessons learned.
Thompson IM
BJU Int; 2007 Jul; 100 Suppl 2():15-7. PubMed ID: 17594351
[No Abstract] [Full Text] [Related]
18. Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.
Pruthi RS; Derksen JE; Gaston K
J Urol; 2003 Jun; 169(6):2304; author reply 2304-5. PubMed ID: 12771783
[No Abstract] [Full Text] [Related]
19. Re: Chemoprevention of urological cancer.
Pitts WR
J Urol; 2000 Apr; 163(4):1260-1. PubMed ID: 10737524
[No Abstract] [Full Text] [Related]
20. Finasteride may prevent prostate cancer.
Thompson CA
Am J Health Syst Pharm; 2003 Aug; 60(15):1511, 1515. PubMed ID: 12951749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
